Ricerca Biosciences, an integrated preclinical contract research organisation (CRO) providing services to the biopharmaceutical industry, has appointed Lynn Miesel as technical director.
In her new role, Miesel will use more than 13 years of industry experience in anti-infectives to lead projects managed by the US-based firm.
Prior to joining Ricerca Biosciences, Miesel worked for Merck Research Laboratories as the biology collaboration lead of infectious disease research. Here she focused on project conception, design and coordination for target validation, lead identification and lead optimisation programmes.
Ricerca Biosciences provides a range of preclinical services from compound screening, profiling and lead optimisation to full drug safety, metabolism and efficacy development support, as well as clinical supply and commercial API production capability.
